Washington D.C. Partner Kevin Madagan of Reed Smith’s Life Science Health Industry group will participate in an exert legal panel discussion at the 2017 Health Care Distribution Alliance (HDA) Traceability Seminar held November 8-10 in Washington D.C.
Implementation of the Drug Supply Chain Security Act (DSCSA) continues to transform the pharmaceutical supply chain. As the industry works toward the law’s 2023 finish line, HDA’s annual traceability seminar brings together healthcare supply chain leaders to learn more about upcoming DSCSA implementation milestones as well as innovative approaches and lessons learned as distributors, manufacturers and dispensers implement serialization and traceability technologies to further preserve the safety and security of the healthcare supply chain.
Among key DSCSA deadlines, pharmaceutical manufacturers will reach a major serialization milestone on November 27, 2017, with FDA enforcement discretion to end one year from that date. HDA, fellow supply chain colleagues, federal and state regulators, and industry traceability experts will provide details on the progress toward this milestone, as well as the status and timelines for implementation, updates on industry projects to support the 2019 deadline to process serialized, saleable returns with a Verification Router Service. The seminar also will cover exceptions handling, 3PL perspectives, challenges and a status update on unit-level serialization, as well as the key regulatory perspectives on the entire process.
This seminar is designed for distributors, pharmacies and supply chain partners responsible for the implementation of traceability strategy, systems and processes in the healthcare supply chain.